[144] Gevo, Inc. SEC Filing

Rhea-AI Filing Summary

Gevo, Inc. (NASDAQ: GEVO) Form 144 filing reports a proposed sale of 120,304 common shares through Stifel Nicolaus on or after 01 Aug 2025. Based on the filing’s stated value of $154,230, the transaction equates to roughly $1.28 per share. With 239,562,995 shares outstanding, the sale would represent only ≈0.05 % of total shares.

The shares were acquired as restricted stock units (RSUs) on 26 Jul 2025; payment will be made in cash. During the past three months, the same account holder—identified in the filing as Pat Gruber—has already sold 157,197 shares for gross proceeds of $201,527.

Form 144 is a notice, not a commitment; the filer may choose not to execute or may amend the amount. No earnings, guidance, or operational updates accompany the notice.

Positive

• None.

Negative

• Insider selling: Proposed sale of 120,304 shares and prior sale of 157,197 shares may signal reduced insider exposure.
• Repeated disposals: Two sales within three months could be viewed negatively by some investors despite small relative size.

Insights

Securities Analyst

TL;DR: Minor Form 144; insider plans to sell 120k GEVO shares (~0.05 % float); limited impact unless selling accelerates.

The proposed sale is small relative to Gevo’s nearly 240 million outstanding shares, translating to minimal dilution or ownership change. Insider activity can signal sentiment, but the dollar value ($154k) is immaterial for most valuation models. The filing provides no operational data, so the core investment thesis remains unchanged. Market reaction, if any, is likely muted.

Corporate Governance Specialist

TL;DR: Repeated insider disposals (157k shares earlier, 120k planned) warrant monitoring but are not inherently alarming.

Pat Gruber’s cumulative intended and completed sales total 277,501 shares within three months. While these trades are permitted under Rule 144 and represent a tiny fraction of the float, sustained selling by key insiders can influence perception of future prospects. Investors should track subsequent Forms 4 and 144 to assess any emerging trend.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common Stock	Stifel Nicolaus & Company Inc 501 N Broadway St. Louis MO 63102	120304	154230.00	239562995	08/01/2025	Nasdaq

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common Stock	07/26/2025	Restricted Stock Units	Issuer			218774	08/01/2025	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Pat Gruber 345 Inverness Dr S Ste 310 Englewood CO 80112	Common Stock	05/30/2025	157197	201527.00

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many GEVO shares are covered by the Form 144 filing?

The notice covers 120,304 common shares of Gevo, Inc.

What is the approximate market value of the GEVO shares to be sold?

The filing lists an aggregate market value of $154,230 for the 120,304 shares.

Who is the insider named in the GEVO Form 144 filing?

The filing references Pat Gruber as the seller in prior transactions; the current sale is for the same account.

When is the planned sale date for the GEVO shares?

The approximate sale date disclosed is 01 August 2025.

What portion of GEVO’s shares outstanding does the proposed sale represent?

Only about 0.05 % of the 239.6 million shares outstanding.